𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biowaiver monographs for immediate release solid oral dosage forms: Ranitidine hydrochloride

✍ Scribed by H. Kortejärvi; M. Yliperttula; J.B. Dressman; H.E. Junginger; K.K. Midha; V.P. Shah; D.M. Barends

Book ID
102402973
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
106 KB
Volume
94
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis

Literature and experimental data relevant to the decision to allow a waiver of in vivo bioequivalence testing for the approval of immediate release (IR) solid oral dosage forms containing ranitidine hydrochloride are reviewed. According to the current Biopharmaceutics Classification System (BCS), ranitidine hydrochloride should be assigned to Class III. However, based on its therapeutic and therapeutic index, pharmacokinetic properties and data related to the possibility of excipient interactions, a biowaiver can be recommended for IR solid oral dosage forms that are rapidly dissolving and contain only those excipients as reported in this study.

📜 SIMILAR VOLUMES

Biowaiver monographs for immediate relea
Biowaiver monographs for immediate release solid oral dosage forms: Amitriptyline hydrochloride
✍ R.H. Manzo; M.E. Olivera; G.L. Amidon; V.P. Shah; J.B. Dressman; D.M. Barends 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing amitriptyline hydrochloride are reviewed. Its therapeutic uses, its pharmacokinetic properties, the possibility of excipient

Biowaiver monographs for immediate relea
Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride
✍ S. Strauch; E. Jantratid; J.B. Dressman; H.E. Junginger; S. Kopp; K.K. Midha; V. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release solid oral dosage forms containing mefloquine hydrochloride as the only active pharmaceutical ingredient (API) are reviewed. The solubility and permeability data of

Biowaiver monographs for immediate relea
Biowaiver monographs for immediate release solid oral dosage forms: Ciprofloxacin hydrochloride
✍ M.E. Olivera; R.H. Manzo; H.E. Junginger; K.K. Midha; V.P. Shah; S. Stavchansky; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated immediate release (IR) solid oral dosage forms containing ciprofloxacin hydrochloride as the only active pharmaceutical ingredient (API) are reviewed

Biowaiver monographs for immediate relea
Biowaiver monographs for immediate release solid oral dosage forms: Metoclopramide hydrochloride
✍ A.G. Stosik; H.E. Junginger; S. Kopp; K.K. Midha; V.P. Shah; S. Stavchansky; J.B 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Literature data are reviewed relevant to the decision for a biowaiver of immediate release (IR) solid oral dosage forms containing metoclopramide hydrochloride. In addition, new solubility data, obtained under Biopharmaceutics Classification System (BCS) conditions are presented. Metoclopramide HCl